This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Andrew Blauvelt, MD

Arch Dermatol. 1996;132(12):1503-1504.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

DAMAGE TO the liver with impairment of hepatic uroporphyrinogen decarboxylase can lead to the development of sporadic porphyria cutanea tarda (PCT).¹ In older studies, agents most commonly implicated in the induction of PCT included alcohol, estrogens, iron, polychlorinated hydrocarbons, and hepatitis B virus. Recently, however, PCT has been frequently associated with infections by other viruses, namely, hepatitis C virus (HCV)^2-5 and human immunodeficiency virus (HIV).^6-9 Two studies in this issue of ARCHIVES examine these associations in more detail.^10,11 The purposes of this editorial are to review recent information on this topic and to provide practical guidelines to dermatologists on the evaluation for underlying HCV and HIV infection in patients with photosensitivity or overt PCT.

Screening measures to detect hepatitis A and B viruses in the blood supply were developed in the early 1970s, and soon thereafter it became surprisingly clearthat most cases of transfusion-associated hepatitis were not due to these viruses, but to another agent, . . . [Full Text PDF of this Article]

Author Affiliations
Dermatology Branch National Cancer Institute Bldg 10/Room 12N238 10 Center Dr MSC 1908 Bethesda, MD 20892-1908 (e-mail: Andrew_Blauvelt@nih.gov)

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?